middle.news
Neurotech Advances NTI164 with FDA IND Clearance and Patent Progress
10:59am on Friday 31st of July, 2026 AEST
•
Healthcare
Read Story
Neurotech Advances NTI164 with FDA IND Clearance and Patent Progress
10:59am on Friday 31st of July, 2026 AEST
Key Points
FDA clears IND for NTI164 enabling US clinical trials
US patent applications receive Notices of Allowance
Authorised Prescriber program expands to seven sites
Quarterly cash burn at $1.9 million with $2.4 million cash
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neurotech International (ASX:NTI)
OPEN ARTICLE